Intratumoral Injection: Clinical Trials

3 trials for Intratumoral Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 terminated. 2 Phase 1, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Recruiting 1, Terminated 1
Not applicable1Recruiting 1
Phase 21Recruiting 1

Follow Intratumoral Injection: new trials by email Literature Review of Intratumoral Injection trials Research Report on Intratumoral Injection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I Study of RiMO-401 With Radiation in Advanced Tumors
RiMO-401 - Advanced Solid Tumor, Intratumoral Injection
Phase 1TerminatedCoordination Pharmaceuticals, Inc.52024-02-222025-09-17
The Clinical Efficacy and Safety of Intratumoral Injection of Chemotherapy for Advanced Solid Tumors
Intratumoral Injection of Chemotherapy - Intratumoral Injection, Cancer
Not applicableRecruitingWuxi People's Hospital2002023-09-012024-05-28
Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer
RiMO-301 - Head Neck Cancer, Intratumoral Injection
Phase 1 / Phase 2RecruitingCoordination Pharmaceuticals, Inc.162023-04-032025-09-17

Narrower conditions

Head and Neck Neoplasms (1)  ·  Neoplasms (1)

Broader conditions

Neoplasms (1)  ·  Neoplasms by Site (1)

Interventions

Radiation (1)

Sponsors

Coordination Pharmaceuticals, Inc. (2)  ·  Wuxi People's Hospital (1)

Countries

United States (2)  ·  China (1)

Top investigators

Lawrence Feldman, MD (1)